What Is Xanthelasma

  • Haajar Dafiri BSc (Hons), Biochemistry, University of Wolverhampton, UK

Get health & wellness advice into your inbox

Your privacy is important to us. Any information you provide to us via this website may be placed by us on servers. If you do not agree to these placements, please do not provide the information.

Best Milk Alternative

Xanthelasma, or xanthelasma palpebrarum (XP), is a rare, thin, yellow growth that occurs due to the accumulation of fatty, lipid, and cholesterol deposits around the eyes or corner of the eyelids. It can often be an indicator of other health conditions, including diabetes, hyperlipidemia, and thyroid problems. 

This article will delve into the comprehensive examination of xanthelasma, covering its’ malignancy status,’ risk factors, prevention strategies, diagnosis, current treatment options, and other pertinent aspects.


Xanthelasma, or xanthelasma palpebrarum (XP), is a yellow growth or lump that typically presents around the periorbital areas (eyes or corner of the eyelids).1 Although less common, it may also appear on the neck, trunk, shoulders, and axillae(armpits). 

Despite being a growth or mass, xanthelasma is fortunately non-cancerous (benign), meaning that it is harmless and does not spread elsewhere in the body.1 However, if left untreated, it can grow bigger in size, causing discomfort. A xanthelasma also does not go away on its own2 and cannot be popped like a pimple; it can only be removed via treatment alone. The main current treatment options for xanthelasma will be discussed below. 

Although harmless, xanthelasma can be a warning sign2 of other health conditions such as: 

  • Diabetes
  • Hyperlipidemia (high cholesterol)
  • Thyroid issues e.g. hypothyroidism 

Having xanthelasma can also increase the risk2 of developing heart problems in the future, including:

  • Heart disease
  • Heart attack
  • Atherosclerosis: thickening of arteries due to accumulation of fatty plaque deposits 

Xanthelasma is rare, with a prevalence estimated at only 4% worldwide.1 However, it is the most common type of xanthoma.2 Xanthomas are a group of skin lesions caused by lipid or cholesterol deposits around the eyes or corner of the eyelids. 


According to recent research studies, xanthelasma is caused by the build-up of lipids or cholesterol (hyperlipidemia) around the eyes or corner of the eyelids.

Many factors can cause hyperlipidemia and, eventually, xanthelasma including:1,2 

  • Genetic mutations in certain receptors or enzymes important in lipid metabolism 
  • Certain conditions, such as:
    • Diabetes mellitus 
    • Thyroid problems: e.g. hypothyroidism 
    • Nephrotic syndrome
  • Pregnancy
  • Obesity or weight gain
  • Excessive alcohol intake
  • Inflammation 
  • Certain medications: such as:
    • Oestrogen 
    • Tamoxifen 
    • Prednisolone 
    • Oral retinoids 
    • Cyclosporine 
    • Protease inhibitors

Risk factors 

Certain risk factors increase the risk of developing xanthelasma including:1,2

  • Sex: research suggests that women (1.1%) are more likely to develop xanthelasma than men (0.3%)1
  • Age: although xanthelasma can affect anyone between the ages of 15 to 73 years old, xanthelasma has been demonstrated to affect more people between the ages of 35 and 55 years old
  • Excess weight: overweight or obesity
  • History of smoking and/or alcohol abuse
  • Family history of xanthelasma and/or high cholesterol
  • Certain conditions: such as:
    • Diabetes
    • High blood pressure

Signs and symptoms

Xanthelasma is usually asymptomatic,2 however, upon inspection, xanthelasmas appear as yellow, lipid deposits around the eyes or corner of the eyelids with the following signs and characteristics:1,2 

  • Flat (plaques) or bumpy (papules)
  • Soft or firm
  • Symmetrical 
  • Bilateral (on both sides of the eyes)
  • Thin 
  • Discomfort 


Although no tests are required to diagnose xanthelasma, a healthcare provider may order the following tests to be performed to provide a diagnosis2 for a suspected patient: 

  1. Physical examination: the healthcare provider will examine the skin around the patient’s eyelids. The patient may have one, or more than one xanthelasma.
  2. Blood test: the healthcare provider may order a blood test to be performed to check the levels of the following:
    • Cholesterol: to determine whether the patient has high cholesterol 
    • Thyroid: to determine whether the patient has thyroid issues e.g. hypothyroidism 
    • Blood sugar: to determine whether the patient has diabetes 
    • Liver: to determine whether the patient has liver disease 
  3. If any, some, or all of the above markers in the blood test are found to be abnormal, they can be an indicator of xanthelasma. 

Management and treatment options 

As discussed above, the only way to get rid of xanthelasma is via treatment. The main current management and treatment options for xanthelasma as demonstrated in recent research studies include:1

  • Surgery (or ‘’surgical excision’’): often involves using extreme heat and/or small knives to remove xanthelasmas.
  • Laser surgery (or ‘’laser ablation’’), e.g carbon dioxide (CO2) laser therapy, has been demonstrated to be the ‘’gold-standard’’ laser treatment for xanthelasmas.
  • Topical chemical peels ,e.g. trichloroacetic acid (TCA). Research studies suggest that TCA at 70% concentration has the highest clinical efficacy and tolerability, requiring the least number of sessions to remove xanthelasmas. 
  • Liquid nitrogen cryotherapy: used to freeze xanthelasma skin lesions. It is considered to be the primary ‘’first-choice’’ treatment for xanthelasma.
  • Antibiotics,e.g. pingyangmycin, which has an anti-tumour effect. 
  • Radio-frequency ablation: used to remove xanthelasmas followed by stitching afterwards.

Although successful in removing xanthelasmas, xanthelasmas have a high recurrence rate2 (chance of coming back after removal), and therefore, these treatments may need to be performed more than once. Patients are also advised to maintain good cholesterol levels to further lower the recurrence rate of xanthelasmas. 

It is also worthy of noting that the above treatment options carry large side effects2 including: 

  • Pain
  • Scars and/or blisters: particularly from liquid nitrogen cryotherapy 
  • Oedema (intense swelling): particularly from liquid nitrogen cryotherapy 
  • Changes to skin colour
  • Changes to the structure of the eyelids: the eyelids may turn inside out 

Prevention strategies 

To prevent2 and reduce the risk of developing xanthelasmas, people are advised to: 

  • Maintain good cholesterol levels: if your cholesterol levels are high, consider implementing the following strategies:
    • Eat more fruit and vegetables
    • Cut down and limit your saturated fat intake. Saturated fat is often found in animal products such as full-fat dairy (e.g. butter) and red meat, as well as tropical oils (e.g. coconut oil), sweets, and baked goods (e.g. cakes). 
    • Engage in regular exercise and physical activity  
    • Take cholesterol-lowering drugs or ‘’statins.’’ 
  • Avoid and/or stop smoking.
  • Avoid and/or cut down on alcohol intake.
  • Maintain a healthy weight: Lower your weight if overweight or obese. 
  • Manage blood sugar: seek treatment if diabetic immediately. 
  • Lower blood pressure 


To conclude, Xanthelasma presents as a rare, benign and asymptomatic yellow plaque caused by lipid accumulation, predominantly cholesterol, around the eyes and eyelid corners. Despite its benign nature, the disease can signal underlying health issues such as diabetes, hyperlipidaemia and thyroid disorders. Various factors that contribute to elevated cholesterol levels also contribute to the likelihood of Xanthelasma, and its diagnosis involves physical examination and blood tests assessing cholesterol, blood sugar, liver and thyroid levels. While treatment options like surgery, chemical peels, freezing methods and radio-frequency ablation exist, it is crucial to note potential side effects associated with these interventions, such as oedema, scars, blisters, pain and discomfort. 


  1. Laftah Z, Al-Niaimi F. Xanthelasma: An Update on Treatment Modalities. J Cutan Aesthet Surg. 2018 Jan-Mar;11(1):1-6. doi: 10.4103/JCAS.JCAS_56_17. 
  2. Cleveland Clinic. Xanthelasma [Internet]. [cited 2023 September 18]. Available from: https://my.clevelandclinic.org/health/diseases/23385-xanthelasma

Get health & wellness advice into your inbox

Your privacy is important to us. Any information you provide to us via this website may be placed by us on servers. If you do not agree to these placements, please do not provide the information.

Best Milk Alternative
[optin-monster-inline slug="yw0fgpzdy6fjeb0bbekx"]
This content is purely informational and isn’t medical guidance. It shouldn’t replace professional medical counsel. Always consult your physician regarding treatment risks and benefits. See our editorial standards for more details.

Get our health newsletter

Get daily health and wellness advice from our medical team.
Your privacy is important to us. Any information you provide to this website may be placed by us on our servers. If you do not agree do not provide the information.

Haajar Dafiri

Bachelor of Science with Honours – BSc (Hons), Biochemistry, University of
Wolverhampton, UK

Haajar Dafiri is a recent First Class BSc (Hons) Biochemistry graduate from the University of Wolverhampton with over 4 years of academic writing experience.
She has professional experience working in both labs and hospitals such as LabMedExpert and the NHS, respectively. Due to her ‘’outstanding undergraduate’’ academic achievements, she was awarded both the Biosciences Project Prize and the Biochemical Society Undergraduate Recognition Award.

From a young age, whenever words and science were involved, Haajar eagerly followed. Haajar particularly enjoys diving deep into intricate research articles and interpreting, analysing and communicating the scientificfindings to the general public in an easy, fun and organised manner – hence, why she joined Klarity. She hopes her unique, creative and quirky writing style will ignite the love of science in many whilst putting a smile on their faces.

my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818